OPINION
Justice SAYLOR.
This appeal concerns the sustainability of an award of attorneys’ fees against an insurance company under the peer-review provisions of the Motor Vehicle Financial Responsibility Law.
Section 1797 of the Motor Vehicle Financial Responsibility Law (the “MVFRL”),1 captioned “[c]ustomary [1060]*1060charges for treatment,” limits the amount providers may charge for treatment, accommodations, products, or services rendered to patients injured in automobile accidents, where the injury is covered by an automobile insurance policy.2 75 Pa. C.S. § 1797(a). The enactment also requires providers to seek remuneration directly from insurers and bars provider recourse against covered patients with regard to the difference between the provider’s ordinary charges and those paid by insurers. See id.
In furtherance of the same underlying cost-containment objective, the statute also establishes a process by which insurers may contest their obligation to fund treatment, through implementation of a “peer review plan.” Id. at § 1797(b)(1). These plans entail contracts between insurance companies and “peer review organizations” (“PROs”), which are approved by the Insurance Department to evaluate the reasonableness and necessity of treatment. Id.; see also 31 Pa. Code § 69.55 (delineating the Department’s application and approval process for PROs). If, upon a timely challenge, a PRO determines that treatment is unreasonable or unnecessary, the provider may not collect (or must return with interest) any related payments. See 75 Pa.C.S. §' 1797(b)(7).
In the present case, an individual obtained treatment from Appellee, Herd Chiropractic Clinic, P.C. (“Provider”), for injuries sustained in a motor vehicle accident. The automobile insurer for the patient’s family, Appellant State Farm Mutual Automobile Insurance Company (“Insurer”), submitted Provider’s invoices to a PRO pursuant to Section 1797(b). The PRO determined that certain chiropractic treatments were not necessary or reasonable, and Insurer refused to pay for such treatment.
Provider then commenced a civil action against Insurer, seeking compensation for unpaid bills in the amount of $1380. Provider also sought treble damages and attorneys’ fees, under the theory that these are authorized under Section 1797(b)(4) and (6), which provide as follows:
(4) Appeal to court. — A provider of medical treatment or rehabilitative services or merchandise or an insured may challenge before a court an insurer’s refusal to pay for past or future medical treatment or rehabilitative services or merchandise, the reasonableness or necessity of which the insurer has not challenged before a PRO. Conduct considered to be wanton shall be subject to a payment of treble damages to the injured party.
[[Image here]]
(6) Court determination in favor of provider or insured. — If, pursuant to paragraph (4), a court determines that medical treatment or rehabilitative services or merchandise were medically necessary, the insurer must pay to the provider the outstanding amount plus interest at 12%, as well as the costs of the challenge and all attorney fees.
75 Pa.C.S. § 1797(b).
On the attorneys’ fee question, in relevant part, Insurer defended on the basis that such an award is authorized, under Section 1797, only where insurers fail to invoke the peer-review process as a prerequisite to refusals to pay for otherwise covered treatments. Insurer stressed that Section 1797(b)(6), on its terms, is implicated only where proceedings have occurred [1061]*1061under Section 1797(b)(4). See 75 Pa.C.S. § 1797(b)(6) (opening with the proviso: “If, pursuant to paragraph (4), ... ”). Since, per its plain language, subsection (b)(4) applies only where an insurer has not invoked the peer-review process, see id. at § 1797(b)(4) (establishing providers’ entitlement to challenge in the courts an insurer’s refusal to pay for treatment, “the reasonableness or necessity of which the insurer has not challenged before a PRO”), it was Insurer’s core position that Section 1797(b)(6) simply cannot apply where an insurer has proceeded with peer review. According to Insurer, Section 1797(b)(5)— which does not authorize fee shifting— reflects the appropriate limits on an award by a court on review of a refusal supported by a peer-review determination. See id. at § 1797(b)(5) (“If a PRO determines that medical treatment [was] ... necessary, the insurer must pay to the provider the outstanding amount plus interest at 12% per year on any amount withheld by the insurer pending PRO review.”).
The common pleas court, however, rejected this position. Initially, the. court observed that Insurance Department regulations authorize provider appeals regardless of whether insurers invoke the peer-review process. See 31 Pa.Code § 69.52(m) (“Upon determination of a reconsideration by a PRO, an insurer, provider or insured may appeal the determination to the courts.”). While recognizing that those regulations facially contemplate initial recourse to a reconsideration process, see generally 75 Pa.C.S. § 1797(b)(2) (“An insurer, provider or insured may request a reconsideration by the PRO of the PRO’S initial determination.”), the court explained that this Court had refused to treat reconsideration as a necessary prerequisite to appeals under the regulations. See Terminato v. Pa. Nat’l Ins. Co., 538 Pa. 60, 71, 645 A.2d 1287, 1293 (1994).
Based on these considerations, the common pleas court reasoned:
it appears that through regulation and judicial interpretations of both the statute and the regulations, any party adversely impacted by a peer review decision has recourse in the nature of a challenge before a court under 75 Pa. C.S. § 1797(b)(4). In such a proceeding under that subsection, the statute further provides that, if the court determines that the treatment was medically necessary, the insurer must pay to the provider the outstanding amount, plus interest “as well as the costs of the challenge and all attorneys fees.” 75 Pa.C.S. § 1797(b)(6).
[[Image here]]
... Had the legislature intended to grant immunity [to insurers that pursue the peer review process] ..., it certainly could have done so, but it did not. We do not believe that the legislature intended that an insurer’s use of a peer review process which results, even if unintentionally, in a decision which during a court proceeding is proved to be flawed, to exempt the insurer from the statute’s requirement that fees be awarded. [Insurer’s] immunity interpretation would, in our opinion, only serve to provide an incentive to all insurers to send all bills to a peer review process in which all semblance of objectivity could be all but ignored, so long as the insurer’s conduct is not “wanton”, and the provider (or an insured) would be left with the enormous expense of seeking redress in the courts with no possibility of recovering those costs and fees.
Herd Chiropractic Clinic v. State Farm Mut. Auto. Ins. Co., No. 2006-CV-01320-CV, slip op. at 6-7, 2009 WL 8482227 (C.P. Dauphin Apr. 30, 2010).
[1062]*1062The common pleas court acknowledged Insurer’s reliance on Barnum v. State Farm Mutual Automobile Insurance Company, 430 Pa.Super. 488, 635 A.2d 155 (1993), which took Insurer’s view of Section 1797(b)(6).3 Nevertheless, the court believed the case had no relevance, since it had been reversed on appeal. See Barnum v. State Farm Mut. Auto. Ins. Co., 539 Pa. 673, 652 A.2d 1319 (1994) (per curiam).
Applying this rationale, the common pleas court found an award of attorneys’ fees proper and mandatory under Section 1797(b)(6), since it had found, separately, that the treatment rendered by Provider was, in fact, reasonable and necessary to address the patient’s injury. Accordingly, and based on Provider’s credited evidence concerning the amount and reasonableness of the fees, the court awarded approximately $27,000.4
On Insurer’s appeal, the Superior Court affirmed on reasoning similar to that of the common pleas court. See Herd Chiropractic Clinic, P.C. v. State Farm Mut. Auto. Ins. Co., 29 A.3d 19 (Pa.Super.2011). According to the intermediate court, “[u]nder section 1797(b)(4), any party adversely impacted by a peer review decision may seek recourse before a court.” Id. at 22.5 Like the common pleas court, the intermediate court appeared to be less concerned with an absence of express statutory authorization of fee shifting than with a lack of specific disapproval. See id. (“There is nothing in the language of [Section 1797] that specifically precludes attorneys’ fees where a peer review decision is challenged and the court finds the treatment reasonable and necessary.”).6 In terms of Barnum, the court opined that the decision concerned an insurer’s liability for exemplary damages but did not address attorneys’ fees. See id. But see supra note 3.
We allowed the present appeal to resolve the salient question of statutory interpretation, as to which our review is plenary.
Presently, Insurer relies upon the default rule in Pennsylvania that litigants bear responsibility for their own attorneys’ fees in the absence of express statutory authorization for fee awards, contractual fee-shifting, or some other recognized exception. See Merlino, 556 Pa. at 425, 728 [1063]*1063A.2d at 951 (citing Chatham Commc’ns, Inc. v. Gen. Press Corp., 463 Pa. 292, 300-01, 344 A.2d 837, 842 (1975)). Since, in the circumstances before us, there is no agreement reallocating fees and no claim to any-recognized exception other than statutory authorization, Insurer’s main argument segues into a review of Section 1797.
In this regard, Insurer maintains that the common pleas and intermediate courts “completely misread” the statute, since subsections 1797(b)(4) and (b)(6), by their plain terms, authorize fee awards only in the absence of peer review. Brief for Insurer at 9, 12.7 Insurer highlights the Superior Court’s previous indication that, “when the peer review process hás been followed, as it was here, the insurer’s potential liability is limited to the amount of the claim plus interest.” Id. at 9 (citing Barnum, 430 Pa.Super. at 493, 635 A.2d at 157).8 According to Insurer, the prior reviewing courts simply ignored the express “words of limitation” in Sections 1797(b)(4) and (b)(6). Id. at 16.
Supplementing its plain language argument, Insurer contends that the Superior Court’s holding undermines the cost-containment aim of the MVFRL, as well as the subsidiary goal of encouraging insurers to engage the peer-review process. See id. at 10 (“If the Superior Court’s decision below is allowed to stand and attorney’s fees are to be awarded every time a court overturns a peer review decision, insurers would have absolutely no incentive to first seek a peer review of questionable medical bills.”); accord Brief for Amicus Pa. Defense Inst, at 8 (positing that a “chilling effect on policing unreasonable and unnecessary medical expenses” results from the intermediate court’s holding, which “will undoubtedly increase insurance costs for all Pennsylvania insurance consumers”).
Insurer also asserts that this Court’s Terminato decision pertained solely to the question of whether reconsideration of a PRO determination is a prerequisite to judicial review invoked by an insured under the salient Insurance Department regulation. See Terminato, 538 Pa. at 63, 645 A.2d at 1288. Elaborating on this position, Insurer contends as follows;
The effect of the Court’s ruling [in Ter-minato ] was to expand [that regulation, ie.,] 31 Pa.Code § 69.52(m) to allow court redress without a reconsideration being performed. It is through this regulation, and not through 75 Pa.C.S. § 1797(b)(4), that court action is authorized where a peer review has been performed.
Conversely, if no peer review is performed, then an appeal to [c]ourt is pursuant to 75 Pa.C.S. § 1797(b)(4).
[1064]*1064Reply Brief for Insurer at 5 (emphasis in original). Insurer also stresses that Ter-minato simply did not discuss the range of appropriate damages, including whether and/or when attorneys’ fees may be appropriate. Finally, responding to a series of policy arguments advanced by Provider, Insurer counters:
Although [Provider] seeks to attack the [peer review] system as a whole, such arguments are misdirected, not at issue before this Court, and better put to the Legislature.... At its heart, the present case concerns statutory interpretation only. [Provider’s] arguments against the system are wholly irrelevant and seek only to cloud the straight-forward issue presented to the Court.
Id. at 3.
Provider, on the other hand, asserts that, under Section 1797, “[t]here is no statutory distinction between mandatory damages of the outstanding medical bills amount, interest and all attorney fees.” Brief for Provider at 5. It is Provider’s position that Section 1797(b)(6) applies on its terms whenever a court determines that medical treatment was necessary, regardless of whether or not peer review was pursued by an insurer. See id. Furthermore, Provider highlights the Superior Court’s observation that Section 1797 does not expressly preclude attorneys’ fees for any reason, including cost-containment. Although Provider discusses various of the provisions of Section 1797, its arguments consistently flow into policy statements and explications. See, e.g., id. at 7 (“1 Pa.C.S. § 1922(2) states the presumed intent of the Legislature is that it ‘intends the entire statute to be effective and certain.’ A reading of 1797 in its entirety indicates a public policy to make health care providers whole.”); see also id. (contending that fee awards against insurers inure to the public interest).
In one instance in which Provider does focus on the statutory language, it concedes that “[a] first reading of 1797(b)(4) indicates that an appeal to [c]ourt occurs when ‘the insurer has not challenged (the medical bills) before a PRO.’ ” Brief for Provider at 9 (quoting 75 Pa.C.S. § 1797(b)(4)). Provider, however, suggests that this Court rejected such a reading in Terminato, as a corollary to its holding that an insured may challenge a peer-review determination in court, without a threshold request for reconsideration asserted within the peer-review system. See id. at 10 (“Since § 1797(b)(4) and (6) are the only sections of 1797 that pertain to a[c]ourt’s determination!,] then the damages in § 1797(b)(6) must apply. It is illogical to reason that Terminato stands for the proposition that § 1797 grants a provider the right to appeal a peer review to Common Pleas but does not entitle the provider to the damages expressly stated in the statute following a[c]ourt determination.”). Moreover, Provider observes, Insurer does not challenge the award of statutory interest; thus, according to Provider, Insurer should not be permitted to “pick those damages from the statute which it deems applicable and ignore other damages.” Id.
In terms of Insurer’s argument predicated on the cost-containment aims of the MVFRL, Provider references recent expressions from a majority of Justices confirming that the remedial purposes of the statute must also be taken into account. See, e.g., Williams v. GEICO Gov’t Emps. Ins. Co., 613 Pa. 113, 136-37, 32 A.3d 1195, 1210 (2011) (Saylor, J., concurring); id. at 136-39, 32 A.3d at 1210-11 (Baer, J., concurring); id. at 141-42, 32 A.3d at 1213 (Todd, J., concurring, joined by McCaffery, J.). With regard to Bam/wm, Provider notes that the salient passage of the opinion was dictum, which Provider believes to [1065]*1065be erroneous in any event. To the degree that Insurer relies on Section 1797(b)(5), it is Provider’s position that Insurer “misapprehends that 1797(b)(5) acts to grant [Provider] immunity from attorney fees which is the same argument rejected by the Superior and Trial Courts.” Brief for Provider at 19.
As noted, Provider advances lengthy policy arguments. Principally, Provider contends that health care providers need “real access” to the courts, because the peer review system is biased in favor of its revenue source, namely, the insurance industry. Brief for Provider at 23.9 Along these lines, Provider highlights the Termi-nato Court’s expressed skepticism of the peer-review system. See, e.g., Terminato, 538 Pa. at 68, 645 A.2d at 1291 (“The detachment and neutrality required of a fact-finder is conspicuously absent in the contractual relationship between a PRO and an insurer.”). According to Provider, reversal of the Superior Court’s decision “will have a chilling effect on health care.” Brief for Provider at 45. Finally, Provider also offers its own tally concerning the interpretations of Section 1797(b)(6) in the federal and state courts, see id. at 39-44; see, e.g., Miller v. Allstate Fire & Cas. Ins. Co., Civil No. 07-260, 2009 WL 577964, at *7 (W.D.Pa. Mar. 5, 2009), and, in any [1066]*1066event, admonishes that “a score card argument is not an appropriate rationale to offer this Court.” Brief for Provider at 43.
Upon review of the above arguments, we find Insurer’s to be correct in material respects. As Insurer notes, this Court has consistently followed the general, American rule that there can be no recovery of attorneys’ fees from an adverse party, absent an express statutory authorization, a clear agreement by the parties, or some other established exception. Merlino, 556 Pa. at 425, 728 A.2d at 951. Since no agreement or other (non-statutory) exception has been identified, to be sustainable, the fee award attained by Provider must gain grounding from some express term of Section 1797. See id. at 426, 728 A.2d at 951.10
Section 1797(b)(4), however, authorizes appeals by providers from insurer refusals to pay for treatment, “the reasonableness or necessity of which the insurer has not challenged before a PRO.” 75 Pa. C.S. § 1797(b)(4) (emphasis added). Moreover, by its opening proviso, Section 1797(b)(6) — which contains the statute’s sole authorization of fee shifting — is expressly tied to subsection (b)(4). See id. at § 1797(b)(6) (“If, pursuant to paragraph (4), a court determines ... ”). Thus, both subsections, by their explicit terms at least, apply only in the circumstance in which an insurer has not pursued peer review. There is, as Insurer emphasizes, simply no express statutory authorization for fee shifting on provider challenges to peer-review determinations. It is true that the Insurance Department regulation sanctioning such provider appeals serves to alleviate due process concerns arising out of the Legislature’s failure to provide for this category of challenges. See generally Terminato, 538 Pa. at 72 n. 3, 645 A.2d at 1293 n. 3. The regulation, nonetheless, neither provides for fee shifting nor serves to bootstrap the statutory fee-shifting requirement pertaining to non-peer-reviewed insurer refusals into the peer-review arena.11
We acknowledge Provider’s concerns with the financial incentives in the peer-review industry and with the fact that litigation costs incurred by providers may discourage legitimate challenges. The fee accruals here — in the amount of $27,000 to vindicate a $1380 claim — present a stark example of the difficulty. Moreover, we appreciate that Section 1797 is neither comprehensive nor a model of clarity, in various respects. Nevertheless, fee shift[1067]*1067ing raises a host of mixed policy considerations in and of itself, which this Court has found are best left to the General Assembly, in the absence of contractual allocation or some other recognized exception to the general, American rule. The Legislature’s failure to adjust Section 1797 over time as imperfections have been revealed by experience, while unfortunate, does not alter the functions ascribed to our respective branches of government. Accordingly, in the absence of a demonstrated constitutional infirmity, courts generally must apply plain terms of statutes as written; they are to confine efforts to effectuate legislative intent — above and beyond the prescriptions of written laws — to ambiguous provisions; and they are to enforce the longstanding responsibility allocated to the policymaking branch to provide for fee shifting, when it is deemed appropriate, through explicit pronouncements.
The dissent’s primary position is that due process requires mandatory attorneys’ fee awards in the PRO setting, and it suggests that such fee shifting may be justified as an application of principles of statutory construction. See, e.g., Dissenting Opinion, at 1071 (indicating that there is “ample room to construe [Section 1797] to avoid this violation of due process”).12 We do not discount that there may be due process concerns with the statute which might be raised and considered via a constitutional challenge to its enforcement.13 In terms of addressing the question of statutory interpretation with which we are presented in this appeal, however, we observe the dissent’s construction contradicts Section 1797’s express terms. In this regard, as we have explained, the Legislature has provided for fee awards only in relation to matters pursued under subpar-agraph (b)(4), see 75 Pa.C.S. § 1797(b)(6), which applies only to insurer refusals-to-pay for treatment “the reasonableness or necessity of which the insurer has not challenged before a PRO,” id. § 1797(b)(4) (emphasis added).14 Additionally, contrary to the purport of the dissent, this Court’s Temiinato decision did not effectively channel appeals from PRO decisions through Sections 1797(b)(4) and (b)(6), in derogation of the statute’s plain terms. Rather, Temiinato reflects the far more modest and restrained holding that a statute providing an evaluation process funded by an interested party could not serve to foreclose judicial review on the filing of a civil action in the nature of an appeal from an adverse decision arising from such process. See Terminato, 538 Pa. at 71, 645 A.2d at 1292.
While, as we have otherwise recognized, the dissent’s policy concerns relative to access to justice are not unfounded, these apply equally to a wide range of small-claims scenarios involving deep-pocket defendants and implicate countervailing policy considerations beyond the scope of the [1068]*1068discussion offered by the dissent. In our considered judgment, the present appeal— which is limited to an issue of statutory interpretation — is not an appropriate venue for reconsidering Pennsylvania’s longstanding adherence to the American rule.15
The order of the Superior Court is reversed, and the matter is remanded for conformance of the judgment with this opinion.
Justice ORIE MELVIN did not participate in the consideration or decision of this case.
Chief Justice CASTILLE, Justices EAKIN and TODD join the opinion.
Justice BAER files a dissenting opinion in which Justice McCAFFERY joins.